May 15, 2017 / 12:48 PM / 2 months ago

BRIEF-First patient transfused in Cerus’ phase III RedeS study

1 Min Read

May 15 (Reuters) - Cerus Corp

* First patient transfused in Cerus’ phase III RedeS study evaluating safety and efficacy of the intercept red blood cell system

* Cerus-First patient transfused in puerto rico for intercept blood system for red blood cells in regions at potential risk for zika virus transfusion-transmitted infections trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below